NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Prime Minister Mark Carney and U.S. President Donald Trump had a ‘productive and wide-ranging conversation’ Thursday, according to a readout from the Prime Minister’s Office.Read More